NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
Details
- Buyer
- NHS England
- Supplier(s)
63 suppliers
- AVENTIS PHARMA LIMITED
- Abbvie Ltd
- AGB Pharma
- Aguettant Ltd
- Alissa Healthcare Research Limited
- Amarox Ltd
- Aspire Pharma Ltd
- B. BRAUN MEDICAL LIMITED
- Bowmed Ibisqus Ltd
- Colonis Pharma Limited
- Consilient Health Ltd
- CST Pharma Limited
- Day Lewis Medical Ltd
- Desitin Pharma Ltd
- Dr Reddy's Laboratories (UK) Ltd
- Ennogen HealthCare
- Esteve Pharmaceuticals Ltd
- Flexipharm Austrading Ltd
- FLYNN PHARMA LTD
- FRESENIUS KABI LIMITED
- GENNISIUM PHARMA
- Gerot Lannach UK Ltd
- GH Pharma Ltd
- GLAXOSMITHKLINE UK LIMITED
- Glenmark Pharmaceuticals Europe Ltd
- Hameln Pharma Ltd
- Healthcare Pharma Ltd
- Ipca Laboratories UK Ltd
- Janssen Cilag Ltd
- Kent Pharma Ltd
- Lucane Pharma
- Macleods Pharma UK Limited
- Martindale Pharma
- medac Pharma LLP
- Medreich Plc
- Mercury Pharmaceuticals Ltd
- Milpharm Ltd/aurobinbdo
- Morningside Pharmaceuticals Ltd
- Mylan
- Neuraxpharm UK Ltd
- Novumgen Limited
- Organon Pharmaceuticals UK Ltd
- Otsuka Pharmaceuticals UK Limited
- Panpharma UK Ltd
- PARI
- Perennial Pharma Ltd
- Pfizer Liimted
- Piramal Critical Care Ltd
- Ranbaxy (UK) Ltd
- Roma Pharmaceuticals Limited
- Rosemont Pharmaceuticals Ltd
- ROVI BIOTECH LIMITED
- Sandoz
- Seacross Pharmaceuticals Ltd
- Selective Supplies Ltd
- Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
- Teva UK Ltd
- Thornton and Ross
- Tillotts Pharma UK Ltd
- Torbay Pharmaceuticals
- Venture Healthcare Ltd
- Wockhardt UK Limited
- Zentiva Pharma UK Ltd
- Value
- GBP 1
- Duration
- 3 years
- Topic
- Pharmaceutical products
- Published
- 14 May 2024
- Source
- uk:contracts_finder
Tender description
Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)
Timeline
- Completed: Award published14 May 2024Current notice
- Completed: Award date1 June 2024
- Next: Contract expiry date31 May 2027in 9 months
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1).
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related topics
Topics related to NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1), ranked by notice volume.
- 16,740£389.4bn
- 92,792£10.4tn
Related buyers
Buyers similar to NHS England.
- 464£2.1bn
- 376£250.5m
- 367£15.0bn
- 304£2.8bn
- 271£904.1m
- 268£20.1bn
- 255£517.2m
- 203£1.0bn
- 147£900.8m
- 135£63.9m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
